email@example.com I +33 6 52 97 09 38Voir le site
Startup – Small Biotech
Main field of activity
We collaborate with pharmaceutical companies, CROs, academic researchers and medical doctors to make join development organ on chips in order to accelerate the understanding of neural troubles mechanisms and the discoveries of new treatments.
Neurodegenerative disease, inflammatory disease, immune disorders, skin disease & rare-orphan disease;
Organ development & physiopathology studies, diseases models, organ interaction studies, drug discovery, toxicity, drug safety, toxicology testing & personalized medecine.
NETRI develops technologies that accelerate fundamental and medical research by offering neurofluidic devices to the pharmaceutical companies, CROs and public researchers specialising in neurosciences and neurological disorders.
NETRI’s unique expertise and patented technologies in microfluidic neuroengineering enable the design, manufacture and application of physiologically relevant organ-on-chip in vitro Neurofluidics™ devices. These compartmentalized devices allow the understanding of the structural and functional mechanisms of neurological disorders and the exploration at high throughput of modes of action of a compound on muiner or human cellular networks.
Google Maps est désactivé.
321 avenue Jean Jaurès